Interestingly, Morgan et al. recently showed that a panel of ten proteins, including cytokines eotaxin-1, MCP-1, and MIP-1β, was able to significantly differentiate AD, MCI, and healthy control groups, with subsets of this panel also successful in discerning patients from controls when tested in a discovery cohort [70]. This evidence concerns the gene CCL4 and Alzheimer disease.